Cargando…

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

The development of cancer has historically been attributed to genomic alterations of normal host cells. Accordingly, the aim of most traditional cancer therapies has been to destroy the transformed cells themselves. There is now widespread appreciation that the progressive growth and metastatic spre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emens, Leisha A, Silverstein, Samuel C, Khleif, Samir, Marincola, Francesco M, Galon, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341195/ https://www.ncbi.nlm.nih.gov/pubmed/22490302 http://dx.doi.org/10.1186/1479-5876-10-70

Ejemplares similares

Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012
por: Sunay, Melek Erdinc, et al.
Publicado: (2013)

Introducing the clinical trials monitor: a new section of the journal for immunotherapy of cancer
por: Emens, Leisha A., et al.
Publicado: (2015)

Targeting adenosine for cancer immunotherapy
por: Leone, Robert D., et al.
Publicado: (2018)

Cancer immunotherapy trials: leading a paradigm shift in drug development
por: Emens, Leisha A., et al.
Publicado: (2016)

It’s TIME for a biomarker-driven approach to cancer immunotherapy
por: Emens, Leisha A.
Publicado: (2016)

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
por: Kaufman, Howard L., et al.
Publicado: (2016)

Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015)

Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
por: Wang, Hanwen, et al.
Publicado: (2022)

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
por: Ascierto, Paolo A., et al.
Publicado: (2022)

JTM’s Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section
por: Bot, Adrian, et al.
Publicado: (2013)

Introducing the society for immunotherapy of cancer’s new journal: journal for immunoTherapy of cancer
por: Romero, Pedro J, et al.
Publicado: (2013)

Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies
por: Song, Jian, et al.
Publicado: (2019)

Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice
por: Foote, Jeremy, et al.
Publicado: (2015)

Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
por: Zhang, Ning, et al.
Publicado: (2022)

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment
por: Melo, Vinicio, et al.
Publicado: (2022)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge” (December 4th–5th, 2019, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Editorial on Special Issue “Immunotherapy, Tumor Microenvironment and Survival Signaling”
por: Golubovskaya, Vita
Publicado: (2021)

The immune score as a new possible approach for the classification of cancer
por: Galon, Jérôme, et al.
Publicado: (2012)

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
por: Ascierto, Paolo Antonio, et al.
Publicado: (2020)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
por: Molinero, Luciana, et al.
Publicado: (2019)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
por: Bei, Roberto, et al.
Publicado: (2023)

Editorial On “Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy”
por: Golubovskaya, Vita, et al.
Publicado: (2020)

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
por: Yang, Muyue, et al.
Publicado: (2020)

Targeting hyaluronan accumulation in the tumor microenvironment
por: Li, Xiaoming, et al.
Publicado: (2018)

The Janus Face of Tumor Microenvironment Targeted by Immunotherapy
por: Buoncervello, Maria, et al.
Publicado: (2019)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
por: Falcone, Italia, et al.
Publicado: (2020)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2019)

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
por: Ascierto, Paolo A, et al.
Publicado: (2013)

The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
por: Nelson, Delia, et al.
Publicado: (2014)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
por: Ngiow, Shin Foong, et al.
Publicado: (2020)

The Tumor Microenvironment and Cancer
por: Chen, Zhen, et al.
Publicado: (2014)

The Tumor Microenvironment: A Druggable Target for Metastatic Disease?
por: EBioMedicine
Publicado: (2018)

Tumor microenvironment and immunotherapy of oral cancer
por: Liu, Chang, et al.
Publicado: (2022)

Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Gadiyar, Varsha, et al.
Publicado: (2020)

Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
por: Mockler, Mary B., et al.
Publicado: (2014)

Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
por: Gao, Shan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s1ihdjpo05ssaq3d6nkda82pvo